» Articles » PMID: 23543301

Enhanced Transfection by Antioxidative Polymeric Gene Carrier That Reduces Polyplex-mediated Cellular Oxidative Stress

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2013 Apr 2
PMID 23543301
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To test the hypothesis in which polyplex-induced oxidative stress may affect overall transfection efficiency, an antioxidative transfection system minimizing cellular oxidative stress was designed for enhanced transfection.

Methods: An amphiphilic copolymer (PEI-PLGA) was synthesized and used as a micelle-type gene carrier containing hydrophobic antioxidant, α-tocopherol. Cellular oxidative stress and the change of mitochondrial membrane potential after transfection was measured by using a fluorescent probe (H₂DCFDA) and lipophilic cationic probe (JC-1), respectively. Transfection efficiency was determined by measuring a reporter gene (luciferase) expression level.

Results: The initial transfection study with conventional PEI/plasmid DNA polyplex showed significant generation of reactive oxygen species (ROS). The PEI-PLGA copolymer successfully carried out the simultaneous delivery of α-tocopherol and plasmid DNA (PEI-PLGA/Toco/pDNA polyplex) into cells, resulting in a significant reduction in cellular ROS generation after transfection and helped to maintain the mitochondrial membrane potential (ΔΨ). In addition, the transfection efficiency was dramatically increased using the antioxidative transfection system.

Conclusions: This work showed that oxidative stress would be one of the important factors that should be considered in designing non-viral gene carriers and suggested a possible way to reduce the carrier-mediated oxidative stress, which consequently leads to enhanced transfection.

Citing Articles

A frame-shift mutation in COMTD1 is associated with impaired pheomelanin pigmentation in chicken.

Bi H, Tranell J, Harper D, Lin W, Li J, Hellstrom A PLoS Genet. 2023; 19(4):e1010724.

PMID: 37068079 PMC: 10138217. DOI: 10.1371/journal.pgen.1010724.


Strategies for accelerating osteogenesis through nanoparticle-based DNA/mitochondrial damage repair.

Kim H, Cho H, Lee S, Lyu J, Kim H, Lee S Theranostics. 2022; 12(14):6409-6421.

PMID: 36168629 PMC: 9475457. DOI: 10.7150/thno.77089.


Glucocorticoid Priming of Nonviral Gene Delivery to hMSCs Increases Transfection by Reducing Induced Stresses.

Hamann A, Kozisek T, Broad K, Pannier A Mol Ther Methods Clin Dev. 2020; 18:713-722.

PMID: 32913879 PMC: 7452153. DOI: 10.1016/j.omtm.2020.07.014.


High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells.

Kozisek T, Hamann A, Nguyen A, Miller M, Plautz S, Pannier A J Biol Eng. 2020; 14:16.

PMID: 32467728 PMC: 7238544. DOI: 10.1186/s13036-020-00238-1.

References
1.
Irani K, Xia Y, Zweier J, Sollott S, Der C, Fearon E . Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997; 275(5306):1649-52. DOI: 10.1126/science.275.5306.1649. View

2.
Grandinetti G, Ingle N, Reineke T . Interaction of poly(ethylenimine)-DNA polyplexes with mitochondria: implications for a mechanism of cytotoxicity. Mol Pharm. 2011; 8(5):1709-19. PMC: 3185119. DOI: 10.1021/mp200078n. View

3.
Beyerle A, Long A, White P, Kissel T, Stoeger T . Poly(ethylene imine) nanocarriers do not induce mutations nor oxidative DNA damage in vitro in MutaMouse FE1 cells. Mol Pharm. 2011; 8(3):976-81. DOI: 10.1021/mp1004492. View

4.
Park T, Jeong J, Kim S . Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 2006; 58(4):467-86. DOI: 10.1016/j.addr.2006.03.007. View

5.
Murphy M . How mitochondria produce reactive oxygen species. Biochem J. 2008; 417(1):1-13. PMC: 2605959. DOI: 10.1042/BJ20081386. View